PC
FLGT icon

Pavadi Capital’s Fulgent Genetics FLGT Stock Holding History

Pavadi Capital’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-74,125
Closed -$2.83M – 21
2022
Q3 		$2.83M Sell
74,125
-7,152
-9% -$359K 2.71% 20
2022
Q2 		$4.43M Buy
81,277
+12,944
+19% +$711K 4.02% 15
2022
Q1 		$4.26M Sell
68,333
-6,328
-8% -$417K 3.76% 15
2021
Q4 		$7.51M Buy
+74,661
New +$6.56M 5.7% 4

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Pavadi Capital's FLGT Position: Q4 2022 in Review

Pavadi Capital sold out of Fulgent Genetics (FLGT) in Q4 2022, closing a stake of 74,125 shares — an estimated $2.83M sold.

Pavadi Capital first reported a position in FLGT in Q4 2021 and held it in 4 quarters. The position peaked at $7.51M in Q4 2021. 224 funds tracked by Wall St. Rank hold FLGT as of Q4 2022.

  • Pavadi Capital reported no remaining Fulgent Genetics position as of Q4 2022 after selling out during the quarter.
  • Pavadi Capital sold 74,125 Fulgent Genetics shares in Q4 2022, an estimated $2.83M.
  • Pavadi Capital first reported a position in Fulgent Genetics in Q4 2021 and held it in 4 quarters.
  • Pavadi Capital's Fulgent Genetics position peaked at $7.51M in Q4 2021.
  • 224 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2022.

Based on Pavadi Capital's 13F filing for Q4 2022, filed 14 Feb 2023.